Brazil has the second deadliest coronavirus outbreak. (Representative)
Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford had died, saying they had received data from an investigation into the matter.
The regulator said testing of the vaccine would continue after the volunteer died. He did not provide any further details, citing the medical confidentiality of those involved in the trials.
The Federal University of Sao Paulo, which helps coordinate phase 3 clinical trials in Brazil, separately said the volunteer was Brazilian but did not specify where the person lived.
AstraZeneca stock turned negative and fell 1.7%.
The federal government is already considering purchasing the British vaccine and producing it at its FioCruz biomedical research center in Rio de Janeiro, while a competing vaccine to Sinovac in China is being tested by the Sao State Research Center. Paulo Butantan Institute.
Brazil has the second deadliest coronavirus outbreak, with more than 154,000 killed by COVID-19, after just the United States. It is the third worst epidemic in terms of cases, with more than 5.2 million infected, after the United States and India.
(Except for the title, this story was not edited by GalacticGaming staff and is posted from a syndicated feed.)
